Cargando…
A novel autophagy activator ginsenoside Rh2 enhances the efficacy of immunogenic chemotherapy
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9894730/ https://www.ncbi.nlm.nih.gov/pubmed/36732082 http://dx.doi.org/10.1002/ctm2.1109 |
_version_ | 1784881799597391872 |
---|---|
author | Yang, Jing Zhang, Wei Jia, Lin Shi, Fei Cao, Min Sun, Jichao Xu, Chengchao Li, Zhijie Cheng, Zhiqiang Zhao, Shan‐Chao Wang, Jigang Yang, Chuanbin |
author_facet | Yang, Jing Zhang, Wei Jia, Lin Shi, Fei Cao, Min Sun, Jichao Xu, Chengchao Li, Zhijie Cheng, Zhiqiang Zhao, Shan‐Chao Wang, Jigang Yang, Chuanbin |
author_sort | Yang, Jing |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9894730 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-98947302023-02-06 A novel autophagy activator ginsenoside Rh2 enhances the efficacy of immunogenic chemotherapy Yang, Jing Zhang, Wei Jia, Lin Shi, Fei Cao, Min Sun, Jichao Xu, Chengchao Li, Zhijie Cheng, Zhiqiang Zhao, Shan‐Chao Wang, Jigang Yang, Chuanbin Clin Transl Med Letter to the Editor John Wiley and Sons Inc. 2023-02-02 /pmc/articles/PMC9894730/ /pubmed/36732082 http://dx.doi.org/10.1002/ctm2.1109 Text en © 2022 The Authors. Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Letter to the Editor Yang, Jing Zhang, Wei Jia, Lin Shi, Fei Cao, Min Sun, Jichao Xu, Chengchao Li, Zhijie Cheng, Zhiqiang Zhao, Shan‐Chao Wang, Jigang Yang, Chuanbin A novel autophagy activator ginsenoside Rh2 enhances the efficacy of immunogenic chemotherapy |
title | A novel autophagy activator ginsenoside Rh2 enhances the efficacy of immunogenic chemotherapy |
title_full | A novel autophagy activator ginsenoside Rh2 enhances the efficacy of immunogenic chemotherapy |
title_fullStr | A novel autophagy activator ginsenoside Rh2 enhances the efficacy of immunogenic chemotherapy |
title_full_unstemmed | A novel autophagy activator ginsenoside Rh2 enhances the efficacy of immunogenic chemotherapy |
title_short | A novel autophagy activator ginsenoside Rh2 enhances the efficacy of immunogenic chemotherapy |
title_sort | novel autophagy activator ginsenoside rh2 enhances the efficacy of immunogenic chemotherapy |
topic | Letter to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9894730/ https://www.ncbi.nlm.nih.gov/pubmed/36732082 http://dx.doi.org/10.1002/ctm2.1109 |
work_keys_str_mv | AT yangjing anovelautophagyactivatorginsenosiderh2enhancestheefficacyofimmunogenicchemotherapy AT zhangwei anovelautophagyactivatorginsenosiderh2enhancestheefficacyofimmunogenicchemotherapy AT jialin anovelautophagyactivatorginsenosiderh2enhancestheefficacyofimmunogenicchemotherapy AT shifei anovelautophagyactivatorginsenosiderh2enhancestheefficacyofimmunogenicchemotherapy AT caomin anovelautophagyactivatorginsenosiderh2enhancestheefficacyofimmunogenicchemotherapy AT sunjichao anovelautophagyactivatorginsenosiderh2enhancestheefficacyofimmunogenicchemotherapy AT xuchengchao anovelautophagyactivatorginsenosiderh2enhancestheefficacyofimmunogenicchemotherapy AT lizhijie anovelautophagyactivatorginsenosiderh2enhancestheefficacyofimmunogenicchemotherapy AT chengzhiqiang anovelautophagyactivatorginsenosiderh2enhancestheefficacyofimmunogenicchemotherapy AT zhaoshanchao anovelautophagyactivatorginsenosiderh2enhancestheefficacyofimmunogenicchemotherapy AT wangjigang anovelautophagyactivatorginsenosiderh2enhancestheefficacyofimmunogenicchemotherapy AT yangchuanbin anovelautophagyactivatorginsenosiderh2enhancestheefficacyofimmunogenicchemotherapy AT yangjing novelautophagyactivatorginsenosiderh2enhancestheefficacyofimmunogenicchemotherapy AT zhangwei novelautophagyactivatorginsenosiderh2enhancestheefficacyofimmunogenicchemotherapy AT jialin novelautophagyactivatorginsenosiderh2enhancestheefficacyofimmunogenicchemotherapy AT shifei novelautophagyactivatorginsenosiderh2enhancestheefficacyofimmunogenicchemotherapy AT caomin novelautophagyactivatorginsenosiderh2enhancestheefficacyofimmunogenicchemotherapy AT sunjichao novelautophagyactivatorginsenosiderh2enhancestheefficacyofimmunogenicchemotherapy AT xuchengchao novelautophagyactivatorginsenosiderh2enhancestheefficacyofimmunogenicchemotherapy AT lizhijie novelautophagyactivatorginsenosiderh2enhancestheefficacyofimmunogenicchemotherapy AT chengzhiqiang novelautophagyactivatorginsenosiderh2enhancestheefficacyofimmunogenicchemotherapy AT zhaoshanchao novelautophagyactivatorginsenosiderh2enhancestheefficacyofimmunogenicchemotherapy AT wangjigang novelautophagyactivatorginsenosiderh2enhancestheefficacyofimmunogenicchemotherapy AT yangchuanbin novelautophagyactivatorginsenosiderh2enhancestheefficacyofimmunogenicchemotherapy |